WO2001022978A3 - Autologous marrow stem cell (msc) transplantation for myocardial regeneration - Google Patents
Autologous marrow stem cell (msc) transplantation for myocardial regeneration Download PDFInfo
- Publication number
- WO2001022978A3 WO2001022978A3 PCT/CA2000/001114 CA0001114W WO0122978A3 WO 2001022978 A3 WO2001022978 A3 WO 2001022978A3 CA 0001114 W CA0001114 W CA 0001114W WO 0122978 A3 WO0122978 A3 WO 0122978A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- mscs
- patient
- further comprise
- implanted
- msc
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Developmental Biology & Embryology (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Animal Behavior & Ethology (AREA)
- Wood Science & Technology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Hematology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Rheumatology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Materials For Medical Uses (AREA)
Abstract
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU75004/00A AU7500400A (en) | 1999-09-30 | 2000-09-28 | Autologous marrow stem cell (msc) transplantation for myocardial regeneration |
EP00963823A EP1221956A2 (en) | 1999-09-30 | 2000-09-28 | Autologous marrow stem cell (msc) transplantation for myocardial regeneration |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15670099P | 1999-09-30 | 1999-09-30 | |
US60/156,700 | 1999-09-30 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2001022978A2 WO2001022978A2 (en) | 2001-04-05 |
WO2001022978A3 true WO2001022978A3 (en) | 2001-08-16 |
Family
ID=22560676
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CA2000/001114 WO2001022978A2 (en) | 1999-09-30 | 2000-09-28 | Autologous marrow stem cell (msc) transplantation for myocardial regeneration |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP1221956A2 (en) |
AU (1) | AU7500400A (en) |
WO (1) | WO2001022978A2 (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002008389A2 (en) * | 2000-07-26 | 2002-01-31 | Scimed Life Systems, Inc. | Therapeutic angiogenesis by bone marrow-derived cell transplantation in myocardial ischemic tissue and skeletal muscle ischemic tissue |
US7732199B2 (en) | 2001-07-12 | 2010-06-08 | Geron Corporation | Process for making transplantable cardiomyocytes from human embryonic stem cells |
JP2004535199A (en) | 2001-07-12 | 2004-11-25 | ジェロン コーポレイション | Cardiomyocyte lineage cells produced from human pluripotent stem cells |
US7682825B2 (en) * | 2002-02-06 | 2010-03-23 | Sanbio, Inc. | Differentiation of bone marrow stromal cells to neural cells or skeletal muscle cells by introduction of notch gene |
US7452718B2 (en) | 2004-03-26 | 2008-11-18 | Geron Corporation | Direct differentiation method for making cardiomyocytes from human embryonic stem cells |
EP1855700B1 (en) | 2005-03-07 | 2013-10-30 | SanBio, Inc. | Use of neuronal precursor cells for treatment of central nervous system lesions |
US8889122B2 (en) | 2005-05-09 | 2014-11-18 | Mytogen, Inc. | Cellular cardiomyoplasty as supportive therapy in patients with heart disease |
KR101529317B1 (en) | 2005-06-22 | 2015-06-16 | 아스테리아스 바이오세라퓨틱스, 인크. | Differentiation of primate pluripotent stem cells to cardiomyocyte-lineage cells |
WO2007021210A1 (en) * | 2005-08-15 | 2007-02-22 | Krasnozhenyuk Alexei Dmitrievi | Method for treating diseases caused by vascular diseases |
KR20110005682A (en) | 2008-01-30 | 2011-01-18 | 제론 코포레이션 | Synthetic surfaces for culturing stem cell derived cardiomyocytes |
US20110195054A1 (en) * | 2009-10-06 | 2011-08-11 | Michael Cohen | Preparation And Use Of Stromal Cells For Treatment Of Cardiac Diseases |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5486359A (en) * | 1990-11-16 | 1996-01-23 | Osiris Therapeutics, Inc. | Human mesenchymal stem cells |
US5736396A (en) * | 1995-01-24 | 1998-04-07 | Case Western Reserve University | Lineage-directed induction of human mesenchymal stem cell differentiation |
WO1999003973A1 (en) * | 1997-07-14 | 1999-01-28 | Osiris Therapeutics, Inc. | Cardiac muscle regeneration using mesenchymal stem cells |
-
2000
- 2000-09-28 EP EP00963823A patent/EP1221956A2/en not_active Withdrawn
- 2000-09-28 AU AU75004/00A patent/AU7500400A/en not_active Abandoned
- 2000-09-28 WO PCT/CA2000/001114 patent/WO2001022978A2/en not_active Application Discontinuation
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5486359A (en) * | 1990-11-16 | 1996-01-23 | Osiris Therapeutics, Inc. | Human mesenchymal stem cells |
US5736396A (en) * | 1995-01-24 | 1998-04-07 | Case Western Reserve University | Lineage-directed induction of human mesenchymal stem cell differentiation |
WO1999003973A1 (en) * | 1997-07-14 | 1999-01-28 | Osiris Therapeutics, Inc. | Cardiac muscle regeneration using mesenchymal stem cells |
Non-Patent Citations (6)
Title |
---|
BRUDER S P ET AL: "MESENCHYMAL STEM CELLS IN BONE DEVELOPMENT, BONE REPAIR, AND SKELETAL REGENERATION THERAPY", JOURNAL OF CELL BIOLOGY,US,ROCKEFELLER UNIVERSITY PRESS, NEW YORK, US, vol. 56, no. 3, 1994, pages 283 - 294, XP000865959, ISSN: 0021-9525 * |
FERRARI G ET AL: "Muscle regeneration by bone marrow -derived myogenic progenitors [see comments] [published erratum appears in Science 1998 Aug 14;281(5379):923]", SCIENCE,US,AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE,, vol. 279, 6 March 1998 (1998-03-06), pages 1528 - 1530, XP002098163, ISSN: 0036-8075 * |
KESSLER P D ET AL: "MYOBLAST CELL GRAFTING INTO HEART MUSCLE: CELLULAR BIOLOGY AND POTENTIAL APPLICATIONS", ANNUAL REVIEW OF PHYSIOLOGY,US,ANNUAL REVIEWS, INC., PALO ALTO, CA, vol. 61, 1999, pages 219 - 242, XP000865708, ISSN: 0066-4278 * |
MAKINO S. ET AL: "Cardiomyocytes can be generated from marrow stromal cells in vitro", THE JOURNAL OF CLINICAL INVESTIGATION, vol. 103, no. 5, March 1999 (1999-03-01), pages 697 - 705, XP000990317 * |
PROCKPO D. ET AL: "Marrow stromal cells for nonhematopoietic tissues", SCIENCE, vol. 276, 1997, pages 71 - 74, XP002162972 * |
TOMITA S ET AL: "AUTOTRANSPLANTED MESENCHYMAL STEM CELLS IMPROVE FUNCTION AFTER A MYOCARDIAL INFARCATION", CIRCULATION,US,AMERICAN HEART ASSOCIATION, DALLAS, TX, vol. 98, no. SUPPL. 17, 1998, pages ABS1036, XP000870314, ISSN: 0009-7322 * |
Also Published As
Publication number | Publication date |
---|---|
AU7500400A (en) | 2001-04-30 |
EP1221956A2 (en) | 2002-07-17 |
WO2001022978A2 (en) | 2001-04-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4553272A (en) | Regeneration of living tissues by growth of isolated cells in porous implant and product thereof | |
EP2178460B1 (en) | Cartilage grafts | |
US5643712A (en) | Method for treating and rendering grafts nonthrombogenic and substantially nonimmunogenic using an extracellular matrix coating | |
WO2001022978A3 (en) | Autologous marrow stem cell (msc) transplantation for myocardial regeneration | |
US6713245B2 (en) | Methods for storing neural cells such that they are suitable for transplantation | |
US20030078653A1 (en) | Tissue engineered mitral valve chordae and methods of making and using same | |
RU2012122055A (en) | REMOVING AND RESTORING THE CELL CONTENT IN BODIES AND TISSUES | |
KR101733137B1 (en) | Method of production for 3D cartilage organoid block | |
WO2004009767A3 (en) | Cell therapy for regeneration | |
AU8476698A (en) | Human mesenchymal stem cells from peripheral blood | |
HK1077525A1 (en) | Augentation of organ function | |
KR20140139060A (en) | Tissue-engineered heart valve for transcatheter repair | |
CA2248643A1 (en) | Method of fixing a physiologic mitral valve bioprosthesis | |
ES2004281A6 (en) | Method of treating a synthetic naturally occurring surface with a collagen laminate to support microvascular endothelial cell growth, and the surface itself | |
WO2001007568A3 (en) | Muscle cells and their use in cardiac repair | |
BR8602659A (en) | IMPLANTABLE PROTECTIVE SURFACE FOR IMPLANTATION IN A HUMAN PATIENT AND PROCESS TO TREAT AN IMPLANT INTENDED FOR IMPLANTATION IN A HUMAN PATIENT | |
CA2339182A1 (en) | Improvement of cardiac function by mesenchymal stem cell transplantation | |
WO2002019893A3 (en) | Improved cardiac function through administration of es cells | |
PT2398898E (en) | Method for the cryopreservation of cells, artificial cell constructs or three-dimensional complex tissues assemblies | |
WO2007087519A3 (en) | Mesenchymal stem cell isolation and transplantation method and system to be used in a clinical setting | |
KR20010088865A (en) | Method and device for preparing a dental implant by immersion in a mesenchymal cell culture | |
WO2002024244A3 (en) | Method of preparing and processing transplant tissue | |
Naimi et al. | Ontogeny of human striatal DARPP-32 neurons in fetuses and following xenografting to the adult rat brain | |
CA2272130A1 (en) | Methods for preventing graft rejection in transplantation and for producing a universal gene therapy host cell using lymphocyte activation (lag-3) | |
US20200324022A1 (en) | Elastin reduction allowing recellularization of cartilage implants |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2000963823 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2000963823 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10089710 Country of ref document: US |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2000963823 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: JP |